Phelps, Whitney Magee
September 2001
Albany Law Review;2001, Vol. 65 Issue 1, p243
Academic Journal
Explores Maine's attempt to provide its citizens with affordable medications and prescription drugs. Reason prescription drugs are costly to the elderly in the U.S.; Controversy surrounding Maine's solution; Details of the constitutionality of Maine's healthcare program.


Related Articles

  • High costs prompt some plans to seek savings by splitting pills. Prince, Michael // Business Insurance;8/11/2003, Vol. 37 Issue 32, p4 

    As prescription drug costs continue to escalate, some health plans are looking to have participants split higher-dosage pills as a way to save money. But while some employers encourage this practice as a way to save money, others view the risks as too great. For some popularly prescribed drugs,...

  • Perspectives On The Pharmaceutical Industry. Reinhardt, Uwe E. // Health Affairs;2001 A Primer, p128 

    Characterizes the pharmaceutical industry in the United States. Cost structure of the industry; Effect of drug spending on the economy; Drug spending as a percentage of gross domestic product; Pharmaceutical profits as a source of cost containment; Cost sharing by patients; Price discrimination.

  • Do we pay too much for prescriptions?  // Consumer Reports;Oct93, Vol. 58 Issue 10, p668 

    Examines reasons why prescription drugs are priced highly. Pharmaceutical industry as first targets of health-care reform; Price raising during the 1980s; Profits earned by drug companies; Profits as necessary to attract capital for research and development; Price decisions as within the...

  • Gov't to delay drug price rises. Csonka, Agnes // Budapest Business Journal;06/10/2002, Vol. 10 Issue 27, p4 

    Reports on the Hungarian government's plan of delaying a proposed price increase in prescription drugs receiving state subsidies by six months. Price increase for National Health Fund Administration-subsidized medications by an average of 5 percent; Plans to hike the prices of over-the-counter...

  • Reference-based pricing schemes: effect on pharmaceutical expenditure, resource utilisation and health outcomes. Ioannides-Demos, L.L.; Ibrahim, J.E.; McNeil, J.J.; Ioannides-Demos, Lisa L; Ibrahim, Joseph E; McNeil, John J // PharmacoEconomics;2002, Vol. 20 Issue 9, p577 

    Pharmaceutical expenditure is rising more rapidly than the general inflation rate in most advanced countries. One strategy that has been introduced to control pharmaceutical costs is reference-based pricing (RBP). Its potential is restricted to those specific segments of the drug market where...

  • Prescription market booms with volume growth accelerating. Roller, Kim // Drug Store News;5/22/2000, Vol. 22 Issue 7, p51 

    Focuses on the retail drug prescription market in 1999 in the United States. Market share of chain drug stores; Increase in mail-order sales; Continued increase in prescription volume; Price increase for branded pharmaceuticals.

  • Pricing of prescription drugs and its impact on physicians’ choice behavior. Chen Miao-Sheng; Shih Yu-Ti // Health Care Management Science;Sep2008, Vol. 11 Issue 3, p288 

    This research presents an analysis of Taiwan’s health care market with the focus on the pricing of prescription drugs and its impact on physicians’ choice behavior. Since the advent of Taiwan’s national health insurance, with the competent authority being Bureau of National...

  • Canadian MDs help US 'drug refugees' bypass high prices. Sullivan, Patrick // CMAJ: Canadian Medical Association Journal;1/23/2001, Vol. 164 Issue 2, p244 

    Focuses on citizens of the United States who are traveling to Canada to buy prescription drugs. How prices for medicine in Canada are sometimes half of the cost in the US; Trip made by Philadelphia, Pennsylvania residents to Canada to see physicians and fill prescriptions; How the US does not...

  • A Discount Card Distresses Druggists. Ruth, Joao-Pierre S. // Business News New Jersey;7/31/2001, Vol. 14 Issue 31, p13 

    Discusses a United States government program that would give all seniors on Medicare 10% to 25% discount on prescription drugs purchased at participating pharmacies. Objections raised by the drug store trade groups; Concerns that discount card systems tend to eat away at pharmacies' already low...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics